Français
ItalianoBond Bausch Health Group 5.375% ( USC96729AA31 ) in USD
| Issuer | Bausch Health Group |
| Market price | 100 % ⇌ |
| Country |  Canada
|
| ISIN code |
 USC96729AA31 ( in USD )
|
| Interest rate | 5.375% per year ( payment 2 times a year) |
| Maturity | 15/03/2020 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 2 000 000 000 USD |
| Cusip | C96729AA3 |
| Standard & Poor's ( S&P ) rating | N/A |
| Moody's rating | N/A |
| Detailed description |
Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products. This financial article provides details regarding a specific bond issuance by Bausch Health Companies Inc., a globally recognized Canada-based multinational pharmaceutical entity involved in the development, manufacturing, and marketing of a diverse range of branded, generic, and over-the-counter pharmaceuticals, medical devices, and contact lenses, with a strong focus on eye health, gastroenterology, and dermatology. Identified by the ISIN code USC96729AA31 and the CUSIP code C96729AA3, this particular fixed-income instrument was issued in USD with a total principal amount of $2,000,000,000, offering investors a coupon rate of 5.375% payable semi-annually. The minimum purchase size for this offering was $2,000. Crucially, this bond reached its maturity date on March 15, 2020, at which point its market price was recorded at 100% of its face value, and it has since been fully redeemed, completing the issuer's obligation to its bondholders. |